40321-98-0
Chemical Structure
Mono(2-ethyl-5-oxohexyl) phthalate
Synonym(s): MEOHP; 5-oxo-MEHP
- CAS No.: 40321-98-0
- Formula:C16H20O5
- Molecular Weight:292.33
IUPAC Name: 2-(((2-ethyl-5-oxohexyl)oxy)carbonyl)benzoic acid
InChIKey: HCWNFKHKKHNSSL-UHFFFAOYSA-N
SMILES: O=C(C1=CC=CC=C1C(O)=O)OCC(CC)CCC(C)=O
Biological Activity: Mono (2-ethyl-5-oxohexyl) phthalate (MEOHP; 5-oxo-MEHP) is a secondary metabolite produced by cytochrome P450 enzyme-mediated oxidation of di(2-ethylhexyl) phthalate. Exposure levels of Mono (2-ethyl-5-oxohexyl) phthalate are associated with late-onset hypogonadism. Mono (2-ethyl-5-oxohexyl) phthalate can be used for research on mechanisms related to male reproductive endocrine disorders[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Mono(2-ethyl-5-oxohexyl) phthalate | 99.59% | Mono (2-ethyl-5-oxohexyl) phthalate (MEOHP; 5-oxo-MEHP) is a secondary metabolite produced by cytochrome P450 enzyme-mediated oxidation of di(2-ethylhexyl) phthalate. Exposure levels of Mono (2-ethyl-5-oxohexyl) phthalate are associated with late-onset hypogonadism. Mono (2-ethyl-5-oxohexyl) phthalate can be used for research on mechanisms related to male reproductive endocrine disorders. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mono(2-ethyl-5-oxohexyl) phthalate-d4 | Mono(2-ethyl-5-oxohexyl) phthalate-d4 (MEOHP-d4; 5-oxo-MEHP-d4) is the deuterated-labeled Mono(2-ethyl-5-oxohexyl) phthalate (HY-133676). Mono (2-ethyl-5-oxohexyl) phthalate (MEOHP; 5-oxo-MEHP) is a secondary metabolite produced by cytochrome P450 enzyme-mediated oxidation of di(2-ethylhexyl) phthalate. Exposure levels of Mono (2-ethyl-5-oxohexyl) phthalate are associated with late-onset hypogonadism. Mono (2-ethyl-5-oxohexyl) phthalate can be used for research on mechanisms related to male reproductive endocrine disorders. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Beg MA, et al. Endocrine Disruption: Structural Interactions of Androgen Receptor against Di(2-ethylhexyl) Phthalate and Its Metabolites. Toxics. 2020 Dec 08;8(4):115.
- [2]. Choi K, et al. In vitro metabolism of di(2-ethylhexyl) phthalate (DEHP) by various tissues and cytochrome P450s of human and rat. Toxicology in vitro : an international journal published in association with BIBRA. 2012 Mar;26(2):315-22.
- [3]. Liu ZH, et al. The relationship between exposure to phthalate metabolites and adult-onset hypogonadism. Frontiers in endocrinology. 2022;13:991497.
